Results 231 to 240 of about 183,641 (351)

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Long‐Term Follow‐Up of Deformations and Hemodynamics

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background A detailed evaluation of hemodynamics, supportive morphology, and deformation may help uncover the pathophysiology of hypertrophic obstructive cardiomyopathy (HOCM) and the changes wrought by alcohol septal ablation (ASA). Purpose To investigate the global cardiac volume, myocardial deformation, and hemodynamic characteristics ...
Kenichiro Suwa, Kazuto Ohno, Terumori Satoh, Ryota Sato, Keisuke Iguchi, Yuichiro Maekawa   +5 more
wiley   +1 more source

Modulation of the Renin-Angiotensin System in Critically Ill Patients: Addressing Seven Key Questions for the Intensivist. [PDF]

Anesthesiology
Calabrese A, Bianchi V, Picod A, Bignami EG, Vincent JL, Taccone FS, Annoni F.   +6 more
europepmc   +1 more source

Reduced expression of angiotensin II and angiotensin receptor type 1 and type 2 in resistance arteries from nasal lesions in granulomatosis with polyangiitis (Wegener's granulomatosis)

, 2011
Ivan Dimitrijević, Pehr Rissler, Lena Luts, Lars Edvinsson   +3 more
openalex   +2 more sources

Ontogeny of type 1 angiotensin II receptor gene expression in the rat.

Journal of Clinical Investigation, 1993
A. Tufro-McReddie, Jeffrey K. Harrison, A. Everett, R. A. Gomez   +3 more
semanticscholar   +1 more source

MiR‐145‐5p Attenuates Doxorubicin‐Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Doxorubicin (DOX), a potent anthracycline chemotherapeutic, exhibits dose‐dependent cardiotoxicity that limits its clinical utility. Although miR‐145‐5p demonstrates cardioprotective properties in cardiovascular diseases, its role in DOX‐induced cardiomyopathy remains undefined.
Xing‐Tao Chen, Yong‐Hong Yu, Yan‐Hua Du, Lin Xu, Xiang‐Ping Meng   +4 more
wiley   +1 more source

Angiotensin II Activates Yes-Associated Protein (YAP) in Fibroblast Promoting Deep Fascia Remodeling. [PDF]

Int J Mol Sci
Caroccia B, Caputo I, Bertoldi G, Favaro V, Angelini A, Benetti A, Petrelli L, Di Battista P, Piazza M, Ruggieri P, De Caro R, Stecco C, Pirri C.   +12 more
europepmc   +1 more source

Angiotensin II type 1 receptor gene abnormality in a patient with Bartter's syndrome

, 1994
Hiroaki Yoshida, Junji Kakuchi, Norishige Yoshikawa, Takao Saruta, Tadashi Inagami, John A. Phillips, Iekuni Ichikawa   +6 more
openalex   +1 more source

Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK/AKT/GSK‐3β Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Sacubitril/valsartan (Sac/Val) has emerged as an effective compound with myocardium‐protective functions in experimental and clinical trials for heart failure. This study investigated the function of Sac/Val in hypertensive heart disease (HHD) and explored the underlying mechanism.
Yan‐Jun Yang, Jiu‐Sheng Li
wiley   +1 more source

Quantifying Protein–Glycan Interactions Using Native Mass Spectrometry

Mass Spectrometry Reviews, EarlyView.
ABSTRACT Interactions between glycan‐binding proteins (GBPs) and carbohydrates (glycans) are essential to many biological processes relevant to human health and disease. For most GBPs, however, their glycan interactome—the repertoire of glycans recognized and their specificities—is poorly defined.
Duong T. Bui, Elena N. Kitova, Ling Han, Lara K. Mahal, John S. Klassen   +4 more
wiley   +1 more source

Unlocking the potential of targeting the angiotensin II type 1 receptor in cancer. [PDF]

Oncogene
Butcher DR, Parris CN, Crichton SJ, Dempsey FC, Al-Ali HN.   +4 more
europepmc   +1 more source